Arends M J, Donaldson Y K, Duvall E, Wyllie A H, Bird C C
Department of Pathology, University Medical School, Edinburgh, U.K.
J Pathol. 1991 Dec;165(4):301-9. doi: 10.1002/path.1711650405.
A new type-specific, sensitive, non-radioactive assay is described for the detection of human papillomavirus (HPV) DNA in tissues. Sequences within the E6 gene were amplified by the polymerase chain reaction (PCR), using primer pairs which clearly distinguish HPV types, including those with close sequence homology such as 6b and 11. The amplified DNA products were identified by non-radioactive oligonucleotide hybridization and restriction endonuclease mapping, and the method was sufficiently sensitive to detect between 3 and 5 SiHa cells (each containing 1-2 copies of HPV 16 DNA) amongst 10,000 non-HPV-containing cells. Frozen and archival paraffin sections were equally acceptable substrates for the reaction. The assay was applied to frozen sections of full thickness cervical epithelium from 60 cases of cervical intraepithelial neoplasia (CIN) and 24 normal cervical controls. HPV DNA was detected in 60 per cent of cases of CIN 3 and CIN 2, in 25 per cent of cases of CIN 1, and in none of the normal controls. Prevalence of HPV 16 was similar (approximately 50 per cent) in both CIN 2 and CIN 3, and in the whole series HPV 16 was almost five-fold more common than HPV 18. Low-risk HPV types were present in 5 per cent of CIN 1, but 0 per cent of CIN 2 and CIN 3 biopsies. The data emphasize the biological similarity of CIN 2 and CIN 3 lesions, and their divergence from CIN 1.
本文描述了一种新型的、特异的、灵敏的非放射性检测方法,用于检测组织中的人乳头瘤病毒(HPV)DNA。利用聚合酶链反应(PCR)扩增E6基因内的序列,所使用的引物对能够清晰区分HPV类型,包括那些序列同源性相近的类型,如6b和11型。扩增的DNA产物通过非放射性寡核苷酸杂交和限制性内切酶图谱分析进行鉴定,该方法灵敏度足够高,能够在10,000个不含HPV的细胞中检测出3至5个SiHa细胞(每个细胞含有1 - 2个HPV 16 DNA拷贝)。冷冻切片和存档石蜡切片均是该反应合适的底物。该检测方法应用于60例宫颈上皮内瘤变(CIN)患者的全层宫颈上皮冷冻切片以及24例正常宫颈对照。在CIN 3和CIN 2病例中,60%检测到HPV DNA,CIN 1病例中25%检测到,正常对照中均未检测到。CIN 2和CIN 3中HPV 16的流行率相似(约50%),在整个系列中,HPV 16的常见程度几乎是HPV 18的五倍。低风险HPV类型在5%的CIN 1活检组织中存在,但在CIN 2和CIN 3活检组织中为0%。这些数据强调了CIN 2和CIN 3病变的生物学相似性,以及它们与CIN 1的差异。